300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Hospitality
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
Google
CleanTech
SaaS
Consumer
Health Care
Enterprise Software
Travel
Local
InsurTech
Platforms
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Sports
Wellness
Education
Biotechnology
Legal
Renewable Energy
Automotive
eSports
Facebook
Software
Blockchain
Theatre
Beauty
Medical
Fashion
Web3
Infrastructure
Recruiting
Celebrity
Social
Cannabis
Food and Beverage
LGBT
Life Science
Climate
Real Estate
Publishing
Sporting Goods
Wine and Spirits
Music
Mobile Apps
Art
Finance
Social Media
Manufacturing
Franchise
FinTech
Internet
Android
Mobile Advertising
Impact
Proptech
Hardware
Enterprise
Transportation
Community
Biotech
Sustainability
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Haiti
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uruguay
Uganda
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Sierra Leone
Portugal
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Rwanda
Tanzania
Latvia
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Angola
Bulgaria
Europe
Bahamas
Bahrain
Jersey
Estonia
Cyprus
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Qatar
Cambodia
Iceland
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Venrock, VC Fund

Venrock

VC Fund

Palo Alto, United States

Venrock is a VC fund in Palo Alto focused on Health Care and Biotechnology. Venrock continues a tradition of partnering with entrepreneurs to establish successful, enduring companies. With a primary focus on technology and healthcare, portfolio companies have included Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Endeca, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, Nest, SlideShare, and Tudou.

Total investments:
638
Last investment:
Lead investor:
29%
Fund size:
$500M
Last fund:

Last updated:

Industries Venrock invests in

Health CareBiotechnologySoftwareMedicalInformation Technology

Stages Venrock invests in

Series BSeries ASeries CSeedSeries D

Countries Venrock invests in

United StatesCanadaUnited KingdomIsraelSwitzerland

Round sizes

Series A $3.5M–$50MSeries B $10M–$77MSeries C $11M–$104M

Contacts

NameEmailPhoneSocials
See all 16 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$3.5M–$50M
Series B
$10M–$77M
Series C
$11M–$104M

Investment Focus

Industry

  • Health Care 93 (15%)
  • Biotechnology 88 (14%)
  • Software 62 (10%)
  • Medical 48 (8%)
  • Information Technology 37 (6%)
See all 236 industries →

Stage

  • Series B 123 (19%)
  • Series A 115 (18%)
  • Series C 93 (15%)
  • Seed 55 (9%)
  • Series D 55 (9%)
See all 13 stages →

Country

  • United States 285 (45%)
  • Canada 4 (1%)
  • United Kingdom 4 (1%)
  • Israel 3 (0%)
  • Switzerland 3 (0%)
See all 9 countries →

Team

NameTitleInvestmentsLinksEmail
Partner Total investments: 3
Find email
Anthony Evnin
Anthony Evnin Partner Emeritus
Partner Emeritus Total investments: 17
Find email
Bryan Roberts
Bryan Roberts Partner
Partner Total investments: 74
Find email
Mariana Mihalusova
Mariana Mihalusova Vice President
Vice President Total investments: 3
Find email
Mike Tyrrell
Mike Tyrrell General Partner
General Partner Total investments: 25
Find email
See all 16 team members →

Investments

CompanyDescriptionRoundLinks
Alaunos Therapeutics is a biotechnology company employing a novel gene expression and control technology to deliver DNA for the treatment of cancer. ZIOPHARM's technology platform employs Intrexon Corporation's RheoSwitch Therapeutic System® to turn on and off and precisely modulate gene expression at the cancer site in order to improvethe therapeutic index. This technology is currently being evaluated in Phase 2 clinical studies of the immune system cytokine interleukin-12 for the treatment of breast cancer and advanced melanoma. Multiple new INDs for new targets using similar technology are expected in 2014 and 2015. ZIOPHARM is also developing novel small molecules as potential cancer therapeutics. $350M / Post-IPO Equity / Oct 13, 2026
Suki is an AI-powered, voice-enabled digital assistant for doctors. It was designed to help healthcare organizations with their administrative tasks. Suki helps physicians in dictating notes, retrieving info, and works with EHR. The company was founded in 2017 and is headquartered in Redwood City, California. $90M / Series E / Oct 12, 2026
Carbon Recycle Technologies is a renewable energy company producing bio-methanol and green hydrogen. $50K / Venture - Series Unknown / Oct 07, 2026
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovasculardisease, enabling medical practitioners to treat patients and improve their lives. $275M / Series F / Sep 09, 2026
Aligned Marketplace connects self-insured employers with independent advanced primary and specialty care providers. $20M / Series A / Aug 13, 2026
Expedition Therapeutics operates as an unincorporated association. $115M / Series B / Aug 05, 2026
Arca is an AI-native wealth management firm that pairs human financial advisors with purpose-built AI agents to deliver highly personalized, scalable advice for high-net-worth and growing clients. The company runs an integrated platform that automates operational work $48.5M / Series A / Jun 25, 2026
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions. $180M / Series A / May 20, 2026
GenLogs is a freight intelligence company that offers truck carrier mapping services via AI-driven roadside sensors. $60M / Series B / Feb 02, 2026
FINNY is an AI prospecting tool that provides technology solutions for financial advisors. $17M / Series A / Dec 18, 2025
See all 638 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Hospitality
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
Google
CleanTech
SaaS
Consumer
Health Care
Enterprise Software
Travel
Local
InsurTech
Platforms
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Sports
Wellness
Education
Biotechnology
Legal
Renewable Energy
Automotive
eSports
Facebook
Software
Blockchain
Theatre
Beauty
Medical
Fashion
Web3
Infrastructure
Recruiting
Celebrity
Social
Cannabis
Food and Beverage
LGBT
Life Science
Climate
Real Estate
Publishing
Sporting Goods
Wine and Spirits
Music
Mobile Apps
Art
Finance
Social Media
Manufacturing
Franchise
FinTech
Internet
Android
Mobile Advertising
Impact
Proptech
Hardware
Enterprise
Transportation
Community
Biotech
Sustainability
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Haiti
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uruguay
Uganda
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Sierra Leone
Portugal
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Rwanda
Tanzania
Latvia
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Angola
Bulgaria
Europe
Bahamas
Bahrain
Jersey
Estonia
Cyprus
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Qatar
Cambodia
Iceland
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Venrock invest in?

Venrock invests primarily in Health Care, Biotechnology and Software startups, most often at Series B and Series A stage. Most of the 638 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Venrock invest in?

Venrock typically joins rounds of $3.5M–$50M at Series A, $10M–$77M at Series B and $11M–$104M at Series C. These are whole funding-round sizes, not Venrock's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Venrock took part in.

How do I contact Venrock?

Public channels for Venrock include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Venrock?

The team at Venrock includes Andrew Gottesdiener (Partner), Anthony Evnin (Partner Emeritus) and Bryan Roberts (Partner), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Venrock Venrock Find emails